"Driving Growth in the Peptide and Oligonucleotide CDMO...

added blog Home

2026-02-27 10:41:02 -

"Driving Growth in the Peptide and Oligonucleotide CDMO Market: Key Insights for 2025-2031"

One of the primary driving factors for the peptide and oligonucleotide CDMO market is the escalating adoption of biopharmaceuticals. The rise of peptide-based therapeutics, particularly in oncology, diabetes, and autoimmune diseases, has pushed demand for specialized manufacturing facilities. CDMOs offer essential capabilities in synthesizing high-quality peptides and oligonucleotides at large...

0 Comments 0 Shares 904 Views 0 Reviews